Skip to content
Pill with imprint AA19A, blue & yellow, capsule, 22 mm (Lenalidomide 10 mg)

“Lenalidomide capsules, 10 mg are size "0" hard gelatin capsules, filled with white to off-white powder, imprinted "AA19A" on blue green opaque cap with black ink and pale yellow opaque body”

AA19A pill

Pill with imprint AA19A is blue & yellow, capsule, 22 mm and has been identified as Lenalidomide 10 mg. It is used for multiple myeloma and mantle-cell lymphoma. It is supplied by Amneal Pharmaceuticals Ny LLC.

Lenalidomide 10 mg

Imprint
AA19A
Strength
10 mg
Used for
Multiple myeloma and mantle-cell lymphoma
Color
Blue, Yellow
Shape
Capsule / oblong
Size
22 mm
Score
No score line
Form
Capsule
Manufacturer
Amneal Pharmaceuticals Ny LLC
Drug class
Thalidomide analog
NDC
60219-1716, 60219-1716-1, 60219-1716-2

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Amneal Pharmaceuticals.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lenalidomide pills and guides

What is Lenalidomide used for?

Lenalidomide is used for multiple myeloma and mantle-cell lymphoma.

Medicine type
Thalidomide analog
Official uses from the US prescribing label

Multiple Myeloma

Lenalidomide capsules in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma (MM).

Lenalidomide capsules are indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT).

Myelodysplastic Syndromes

Lenalidomide capsules are indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.

Mantle Cell Lymphoma

Lenalidomide capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

Follicular Lymphoma

Lenalidomide capsules in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL).

Marginal Zone Lymphoma

Lenalidomide capsules in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).

Limitations of Use

Lenalidomide capsules are not indicated and are not recommended for the treatment of patients with CLL outside of controlled clinical trials.

From the FDA-approved label on DailyMed (published Sep 15, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows AA19A.
  • It is blue & yellow, capsule, 22 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Lenalidomide

Inactive: Anhydrous Lactose, Croscarmellose Sodium, Fd&c Blue No. 1, Ferrosoferric Oxide, Ferric Oxide Red, Ferric Oxide Yellow, Gelatin, Magnesium Stearate, Microcrystalline Cellulose, Potassium Hydroxide, Propylene Glycol, Shellac, Titanium Dioxide, Water

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lenalidomide pills